A citation-based method for searching scientific literature

G M Walls, L McConnell, J McAleese, P Murray, T B Lynch, K Savage, G G Hanna, D Gonzalez de Castro. Radiat Oncol 2020
Times Cited: 6







List of co-cited articles
20 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Jeanne Tie, Joshua D Cohen, Yuxuan Wang, Michael Christie, Koen Simons, Margaret Lee, Rachel Wong, Suzanne Kosmider, Sumitra Ananda, Joseph McKendrick,[...]. JAMA Oncol 2019
170
50

An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage.
Aaron M Newman, Scott V Bratman, Jacqueline To, Jacob F Wynne, Neville C W Eclov, Leslie A Modlin, Chih Long Liu, Joel W Neal, Heather A Wakelee, Robert E Merritt,[...]. Nat Med 2014
50

Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling.
Aadel A Chaudhuri, Jacob J Chabon, Alexander F Lovejoy, Aaron M Newman, Henning Stehr, Tej D Azad, Michael S Khodadoust, Mohammad Shahrokh Esfahani, Chih Long Liu, Li Zhou,[...]. Cancer Discov 2017
367
50

Radiotherapy increases plasma levels of tumoral cell-free DNA in non-small cell lung cancer patients.
Shun-Ichiro Kageyama, Keiji Nihei, Katsuyuki Karasawa, Takeshi Sawada, Fumiaki Koizumi, Shigeo Yamaguchi, Shunsuke Kato, Hidehiro Hojo, Atsuhi Motegi, Katsuya Tsuchihara,[...]. Oncotarget 2018
12
50

Detection of circulating tumor DNA in early- and late-stage human malignancies.
Chetan Bettegowda, Mark Sausen, Rebecca J Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R Bartlett, Hao Wang, Brandon Luber, Rhoda M Alani,[...]. Sci Transl Med 2014
50

High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants.
Pedram Razavi, Bob T Li, David N Brown, Byoungsok Jung, Earl Hubbell, Ronglai Shen, Wassim Abida, Krishna Juluru, Ino De Bruijn, Chenlu Hou,[...]. Nat Med 2019
239
33

Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer.
Jeanne Tie, Yuxuan Wang, Cristian Tomasetti, Lu Li, Simeon Springer, Isaac Kinde, Natalie Silliman, Mark Tacey, Hui-Li Wong, Michael Christie,[...]. Sci Transl Med 2016
655
33

Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients.
Jacob J Chabon, Andrew D Simmons, Alexander F Lovejoy, Mohammad S Esfahani, Aaron M Newman, Henry J Haringsma, David M Kurtz, Henning Stehr, Florian Scherer, Chris A Karlovich,[...]. Nat Commun 2016
400
33

Circulating Tumor DNA Analysis for Detection of Minimal Residual Disease After Chemoradiotherapy for Localized Esophageal Cancer.
Tej D Azad, Aadel A Chaudhuri, Penny Fang, Yawei Qiao, Mohammad S Esfahani, Jacob J Chabon, Emily G Hamilton, Yi D Yang, Alex Lovejoy, Aaron M Newman,[...]. Gastroenterology 2020
68
33

Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer.
Thomas Reinert, Tenna Vesterman Henriksen, Emil Christensen, Shruti Sharma, Raheleh Salari, Himanshu Sethi, Michael Knudsen, Iver Nordentoft, Hsin-Ta Wu, Antony S Tin,[...]. JAMA Oncol 2019
230
33

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.
Christopher Abbosh, Nicolai J Birkbak, Gareth A Wilson, Mariam Jamal-Hanjani, Tudor Constantin, Raheleh Salari, John Le Quesne, David A Moore, Selvaraju Veeriah, Rachel Rosenthal,[...]. Nature 2017
750
33

Circulating tumor DNA testing in advanced non-small cell lung cancer.
Everett J Moding, Maximilian Diehn, Heather A Wakelee. Lung Cancer 2018
19
33

Liquid biopsies come of age: towards implementation of circulating tumour DNA.
Jonathan C M Wan, Charles Massie, Javier Garcia-Corbacho, Florent Mouliere, James D Brenton, Carlos Caldas, Simon Pacey, Richard Baird, Nitzan Rosenfeld. Nat Rev Cancer 2017
33

Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung Cancer.
Everett J Moding, Yufei Liu, Barzin Y Nabet, Jacob J Chabon, Aadel A Chaudhuri, Angela B Hui, Rene F Bonilla, Ryan B Ko, Christopher H Yoo, Linda Gojenola,[...]. Nat Cancer 2020
48
33

Senescence, Necrosis, and Apoptosis Govern Circulating Cell-free DNA Release Kinetics.
Ariana Rostami, Meghan Lambie, Caberry W Yu, Vuk Stambolic, John N Waldron, Scott V Bratman. Cell Rep 2020
36
33

Radiation oncology in the era of precision medicine.
Michael Baumann, Mechthild Krause, Jens Overgaard, Jürgen Debus, Søren M Bentzen, Juliane Daartz, Christian Richter, Daniel Zips, Thomas Bortfeld. Nat Rev Cancer 2016
386
33

Early Assessment of Lung Cancer Immunotherapy Response via Circulating Tumor DNA.
Sarah B Goldberg, Azeet Narayan, Adam J Kole, Roy H Decker, Jimmitti Teysir, Nicholas J Carriero, Angela Lee, Roxanne Nemati, Sameer K Nath, Shrikant M Mane,[...]. Clin Cancer Res 2018
177
33

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study.
Jacob G Scott, Anders Berglund, Michael J Schell, Ivaylo Mihaylov, William J Fulp, Binglin Yue, Eric Welsh, Jimmy J Caudell, Kamran Ahmed, Tobin S Strom,[...]. Lancet Oncol 2017
221
33

Prediction of radiation sensitivity using a gene expression classifier.
Javier F Torres-Roca, Steven Eschrich, Haiyan Zhao, Gregory Bloom, Jimmy Sung, Susan McCarthy, Alan B Cantor, Anna Scuto, Changgong Li, Suming Zhang,[...]. Cancer Res 2005
142
33

Circulating mutant DNA to assess tumor dynamics.
Frank Diehl, Kerstin Schmidt, Michael A Choti, Katharine Romans, Steven Goodman, Meng Li, Katherine Thornton, Nishant Agrawal, Lori Sokoll, Steve A Szabo,[...]. Nat Med 2008
33

Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma.
Thanos P Mourikis, Lorena Benedetti, Elizabeth Foxall, Damjan Temelkovski, Joel Nulsen, Juliane Perner, Matteo Cereda, Jesper Lagergren, Michael Howell, Christopher Yau,[...]. Nat Commun 2019
18
16

SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer.
Amanda Blackford, Oscar K Serrano, Christopher L Wolfgang, Giovanni Parmigiani, Siân Jones, Xiaosong Zhang, D Williams Parsons, Jimmy Cheng-Ho Lin, Rebecca J Leary, James R Eshleman,[...]. Clin Cancer Res 2009
250
16


VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2-Study.
Elizabeth Smyth, Maren Knödler, Anne Giraut, Murielle Mauer, Magnus Nilsson, Nicole Van Grieken, Anna Dorothea Wagner, Markus Moehler, Florian Lordick. Front Oncol 2020
25
16

dbSNP: a database of single nucleotide polymorphisms.
E M Smigielski, K Sirotkin, M Ward, S T Sherry. Nucleic Acids Res 2000
315
16

Hematopoietic lineage distribution and evolutionary dynamics of clonal hematopoiesis.
Christopher Maximilian Arends, Joel Galan-Sousa, Kaja Hoyer, Willy Chan, Marten Jäger, Kenichi Yoshida, Ricarda Seemann, Daniel Noerenberg, Nils Waldhueter, Helga Fleischer-Notter,[...]. Leukemia 2018
82
16

Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
Eirini Pectasides, Matthew D Stachler, Sarah Derks, Yang Liu, Steven Maron, Mirazul Islam, Lindsay Alpert, Heewon Kwak, Hedy Kindler, Blase Polite,[...]. Cancer Discov 2018
157
16

The landscape of selection in 551 esophageal adenocarcinomas defines genomic biomarkers for the clinic.
Alexander M Frankell, SriGanesh Jammula, Xiaodun Li, Gianmarco Contino, Sarah Killcoyne, Sujath Abbas, Juliane Perner, Lawrence Bower, Ginny Devonshire, Emma Ococks,[...]. Nat Genet 2019
81
16

Transcriptomic profiling reveals three molecular phenotypes of adenocarcinoma at the gastroesophageal junction.
Jan Bornschein, Lorenz Wernisch, Maria Secrier, Ahmad Miremadi, Juliane Perner, Shona MacRae, Maria O'Donovan, Richard Newton, Suraj Menon, Lawrence Bower,[...]. Int J Cancer 2019
12
16

COSMIC: the Catalogue Of Somatic Mutations In Cancer.
John G Tate, Sally Bamford, Harry C Jubb, Zbyslaw Sondka, David M Beare, Nidhi Bindal, Harry Boutselakis, Charlotte G Cole, Celestino Creatore, Elisabeth Dawson,[...]. Nucleic Acids Res 2019
16

Monitoring the HER2 copy number status in circulating tumor DNA by droplet digital PCR in patients with gastric cancer.
Katsutoshi Shoda, Daisuke Ichikawa, Yuji Fujita, Kiyoshi Masuda, Hidekazu Hiramoto, Junichi Hamada, Tomohiro Arita, Hirotaka Konishi, Shuhei Komatsu, Atsushi Shiozaki,[...]. Gastric Cancer 2017
82
16

White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer.
Alessandro Leal, Nicole C T van Grieken, Doreen N Palsgrove, Jillian Phallen, Jamie E Medina, Carolyn Hruban, Mark A M Broeckaert, Valsamo Anagnostou, Vilmos Adleff, Daniel C Bruhm,[...]. Nat Commun 2020
54
16

Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL.
Christian Winther Eskelund, Simon Husby, Francesco Favero, Tobias Wirenfeldt Klausen, Francisco German Rodriguez-Gonzalez, Arne Kolstad, Lone Bredo Pedersen, Riikka Katariina Räty, Christian H Geisler, Mats Jerkeman,[...]. Blood 2020
10
16

Liquid biopsies to track trastuzumab resistance in metastatic HER2-positive gastric cancer.
De-Shen Wang, Ze-Xian Liu, Yun-Xin Lu, Hua Bao, Xue Wu, Zhao-Lei Zeng, Zekun Liu, Qi Zhao, Cai-Yun He, Jia-Huan Lu,[...]. Gut 2019
57
16

Comparison of Target Enrichment Platforms for Circulating Tumor DNA Detection.
So Ngo Lam, Ying Chun Zhou, Yee Man Chan, Ching Man Foo, Po Yi Lee, Wing Yeung Mok, Wing Sum Wong, Yan Yee Fung, Kit Yee Wong, Jun Yuan Huang,[...]. Sci Rep 2020
11
16

Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.
Maria Secrier, Xiaodun Li, Nadeera de Silva, Matthew D Eldridge, Gianmarco Contino, Jan Bornschein, Shona MacRae, Nicola Grehan, Maria O'Donovan, Ahmad Miremadi,[...]. Nat Genet 2016
211
16

Genomic evidence supports a clonal diaspora model for metastases of esophageal adenocarcinoma.
Ayesha Noorani, Xiaodun Li, Martin Goddard, Jason Crawte, Ludmil B Alexandrov, Maria Secrier, Matthew D Eldridge, Lawrence Bower, Jamie Weaver, Pierre Lao-Sirieix,[...]. Nat Genet 2020
28
16

Droplet digital PCR measurement of HER2 in patients with gastric cancer.
H Kinugasa, K Nouso, T Tanaka, K Miyahara, Y Morimoto, C Dohi, T Matsubara, H Okada, K Yamamoto. Br J Cancer 2015
56
16

Circulating Tumor DNA Sequencing Analysis of Gastroesophageal Adenocarcinoma.
Steven B Maron, Leah M Chase, Samantha Lomnicki, Sara Kochanny, Kelly L Moore, Smita S Joshi, Stacie Landron, Julie Johnson, Lesli A Kiedrowski, Rebecca J Nagy,[...]. Clin Cancer Res 2019
68
16

Analysis of protein-coding genetic variation in 60,706 humans.
Monkol Lek, Konrad J Karczewski, Eric V Minikel, Kaitlin E Samocha, Eric Banks, Timothy Fennell, Anne H O'Donnell-Luria, James S Ware, Andrew J Hill, Beryl B Cummings,[...]. Nature 2016
16

A global reference for human genetic variation.
Adam Auton, Lisa D Brooks, Richard M Durbin, Erik P Garrison, Hyun Min Kang, Jan O Korbel, Jonathan L Marchini, Shane McCarthy, Gil A McVean, Gonçalo R Abecasis. Nature 2015
16

Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer.
Rona Yaeger, Walid K Chatila, Marla D Lipsyc, Jaclyn F Hechtman, Andrea Cercek, Francisco Sanchez-Vega, Gowtham Jayakumaran, Sumit Middha, Ahmet Zehir, Mark T A Donoghue,[...]. Cancer Cell 2018
311
16


Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial.
Puneeth Iyengar, Zabi Wardak, David E Gerber, Vasu Tumati, Chul Ahn, Randall S Hughes, Jonathan E Dowell, Naga Cheedella, Lucien Nedzi, Kenneth D Westover,[...]. JAMA Oncol 2018
409
16

Numerical indices based on circulating tumor DNA for the evaluation of therapeutic response and disease progression in lung cancer patients.
Kikuya Kato, Junji Uchida, Yoji Kukita, Toru Kumagai, Kazumi Nishino, Takako Inoue, Madoka Kimura, Shigeyuki Oba, Fumio Imamura. Sci Rep 2016
14
16

Macrophage biology plays a central role during ionizing radiation-elicited tumor response.
Qiuji Wu, Awatef Allouch, Isabelle Martins, Nazanine Modjtahedi, Eric Deutsch, Jean-Luc Perfettini. Biomed J 2017
39
16

Early detection of pre-malignant lesions in a KRASG12D-driven mouse lung cancer model by monitoring circulating free DNA.
Callum P Rakhit, Ricky M Trigg, John Le Quesne, Michael Kelly, Jacqueline A Shaw, Catrin Pritchard, L Miguel Martins. Dis Model Mech 2019
10
16

Early stage NSCLC - challenges to implementing ctDNA-based screening and MRD detection.
Christopher Abbosh, Nicolai J Birkbak, Charles Swanton. Nat Rev Clin Oncol 2018
140
16

Analysis of circulating tumor DNA by targeted ultra-deep sequencing across various non-Hodgkin lymphoma subtypes.
Seung-Ho Shin, Yeon Jeong Kim, Danbi Lee, Duck Cho, Young Hyeh Ko, Junhun Cho, Woong-Yang Park, Donghyun Park, Seok Jin Kim, Won Seog Kim. Leuk Lymphoma 2019
15
16

Predicting Radiotherapy Responses and Treatment Outcomes Through Analysis of Circulating Tumor DNA.
Aadel A Chaudhuri, Michael S Binkley, Evan C Osmundson, Ash A Alizadeh, Maximilian Diehn. Semin Radiat Oncol 2015
66
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.